Literature DB >> 25820934

[Treatment of acute renal failure in Germany: Analysis of current practice].

M Schmitz1, P J Heering, R Hutagalung, R Schindler, M I Quintel, F M Brunkhorst, S John, A Jörres.   

Abstract

BACKGROUND AND OBJECTIVES: There are currently no reliable data on the differential use of renal replacement therapy (RRT) options for critically ill patients with acute renal failure in Germany. PATIENTS AND METHODS: A questionnaire-based survey was delivered to 2265 German intensive care units. The questionnaire contained 19 questions regarding RRT.
RESULTS: A total of 423 German intensive care units participated in the survey. The offered modalities of RRT varied significantly: the smaller the facility, the fewer different RRT options were available. Intermittent dialysis procedures were available in only 35% of hospitals with up to 400 beds. In university hospitals, hemodynamically unstable patients were exclusively treated by continuous RRT, whereas in hospitals with up to 400 beds, intermittent RRT was also used. In addition, treatment practice was also dependent on the specialization of the treating physicians: Isolated acute renal failure was treated more often intermittently by nephrologists compared to anesthesiologists (79.7 vs. 43.3%). Nephrologists also used extracorporeal RRT more often in cardiorenal syndrome (54.3 vs. 35.8%), whereas anesthesiologists preferred them in sepsis (37.3 vs. 23.1%). The choice of anticoagulant varied as well: Hospitals with up to 400 beds offered regional citrate anticoagulation in only 50% compared to 90% of university hospitals.
CONCLUSIONS: Currently, RRT treatment in acute renal failure on German intensive care units seems to be dependent on the size, local structures, and education of the intensivists rather than patient needs. Our results demonstrate the necessity to establish cross-disciplinary standards for the treatment of acute renal failure in German intensive care units.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25820934     DOI: 10.1007/s00063-015-0014-2

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  27 in total

1.  Impact of real-time electronic alerting of acute kidney injury on therapeutic intervention and progression of RIFLE class.

Authors:  Kirsten Colpaert; Eric A Hoste; Kristof Steurbaut; Dominique Benoit; Sofie Van Hoecke; Filip De Turck; Johan Decruyenaere
Journal:  Crit Care Med       Date:  2012-04       Impact factor: 7.598

Review 2.  Intensity of continuous renal replacement therapy in acute kidney injury.

Authors:  Paul M Palevsky
Journal:  Semin Dial       Date:  2009 Mar-Apr       Impact factor: 3.455

Review 3.  Acute kidney injury: what's the prognosis?

Authors:  Raghavan Murugan; John A Kellum
Journal:  Nat Rev Nephrol       Date:  2011-02-22       Impact factor: 28.314

Review 4.  Heparin-induced thrombocytopenia in critically ill patients.

Authors:  Theodore E Warkentin
Journal:  Semin Thromb Hemost       Date:  2015-01-15       Impact factor: 4.180

Review 5.  Extracorporeal therapies in sepsis.

Authors:  Anthi Panagiotou; Sérgio Gaiao; Dinna N Cruz
Journal:  J Intensive Care Med       Date:  2011-10-25       Impact factor: 3.510

6.  Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration.

Authors:  P Heering; S Morgera; F J Schmitz; G Schmitz; R Willers; H P Schultheiss; B E Strauer; B Grabensee
Journal:  Intensive Care Med       Date:  1997-03       Impact factor: 17.440

7.  Temporal changes in incidence of dialysis-requiring AKI.

Authors:  Raymond K Hsu; Charles E McCulloch; R Adams Dudley; Lowell J Lo; Chi-yuan Hsu
Journal:  J Am Soc Nephrol       Date:  2012-12-06       Impact factor: 10.121

8.  Continuous venovenous haemofiltration using a citrate buffered substitution fluid.

Authors:  M Schmitz; G Taskaya; J Plum; M Hennersdorf; C Sucker; B Grabensee; G R Hetzel
Journal:  Anaesth Intensive Care       Date:  2007-08       Impact factor: 1.669

9.  Hemofiltration in sepsis: where do we go from here?

Authors:  J A Kellum; R Bellomo
Journal:  Crit Care       Date:  2000-02-16       Impact factor: 9.097

10.  Continuous venovenous haemofiltration with citrate-buffered replacement solution is safe and efficacious in patients with a bleeding tendency: a prospective observational study.

Authors:  Shaikh A Nurmohamed; Borefore P Jallah; Marc G Vervloet; Gul Yldirim; Pieter M ter Wee; A B Johan Groeneveld
Journal:  BMC Nephrol       Date:  2013-04-18       Impact factor: 2.388

View more
  1 in total

Review 1.  [Regional citrate anticoagulation in renal replacement therapy in the intensive care station : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI].

Authors:  M Schmitz; M Joannidis; D Czock; S John; A Jörres; S J Klein; M Oppert; V Schwenger; J Kielstein; A Zarbock; D Kindgen-Milles; C Willam
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-05-08       Impact factor: 0.840

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.